Search Results from Other Databases

 
Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation Therapy
Kukui Ahi Navigator Cancer Screening and Treatment Demonstration Project
Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver
Acupuncture in Reducing Ileus in Patients Who Have Undergone Surgery for Colorectal Cancer
Biomarkers and Radiation Side Effects in Patients Undergoing Radiation Therapy for Gastrointestinal Cancer
Registry for Women Who Are At Risk Or May Have Lynch Syndrome
Study Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography to Detect Hypoxia in Locally Advanced (T3-T4 and./or N1)Primary Recta
MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal Cancer
Personalized Screening Plans to Increase Colorectal Cancer Screening in Healthy Participants
Vaccine Therapy and Cyclophosphamide in Treating Patients Who Have Undergone Surgery for Liver Metastases Due to Colorectal Cancer
Health Education Materials With or Without a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III C
Combination Chemotherapy in Treating Patients Undergoing Surgery for Rectal Cancer
Cetuximab and/or Dasatinib in Treating Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery
Increasing Colorectal Cancer Screening in African Americans
Bispecific Antibody in Finding Tumor Cells in Patients With Colorectal Cancer
Studying Tissue Samples From Patients With Stage II Colon Cancer Treated on Clinical Trial CLB-9581
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Patients and Healthy Participants Undergoing Colonoscopy, Endoscopy, or Surger
Comparison of on Demand Sedation With Study Method Versus on Demand Sedation With Conventional Method for Performing Colonoscopy for Colorectal Cancer
Studying Lymph Nodes in Patients With Stage II Colon Cancer
177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors
Capecitabine, Panitumumab, and Radiation Therapy With or Without Irinotecan Hydrochloride in Treating Patients Undergoing Surgery for Localized Rectal
Personal Electronic Health Records in Improving Screening Rates for Colorectal Cancer
Open-Label Phase 2 Efficacy Trial of Cancer Macrobeads in Patients With Treatment-Resistant Pancreatic or Colorectal Cancer
A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Early Removal of Urinary Catheters in Patients After Rectal Surgery: a Prospective Study
Colorectal Cancer Umbrella Protocol - Assessment of Targeted Therapies Against Colorectal Cancer (ATTACC Program) Screening Protocol
Oral Green Tea Extract and Milk Thistle Extract to Colorectal Cancer Patients Undergoing Resection
Cancer Stem Cell Markers and Prognostic Markers in Circulating Tumor Cells
Systems Intervention to Promote Colorectal Cancer (CRC) Screening
A Study of the Safety and Biological Activity of Intraperitoneal (IP) EGEN-001 Administered Alone and in Combination With Standard Chemotherapy in Col
Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Hav
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
CYCORE: Cyberinfrastructure for Comparative Effectiveness Research - Feasibility Trial
Unsedated Colonoscopy for Colorectal Cancer Screening and Surveillance
Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders
Evaluation for NCI Surgery Branch Clinical Studies
The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic Cancer
Dose Finding Study of Once or Twice Weekly IMMU-130 in Metastatic Colorectal Cancer
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer
Educational Program to Increase Colorectal Cancer Screening: a Cluster Trial
Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab
ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (C
NSABP Patient Registry and Biospecimen Profiling Repository
A Phase I Study of Nilontinib and Cetuximab in Patients With Solid Tumors
Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients
Phase 2 Study of MK-3475 in Patients With Microsatellite Unstable (MSI) Tumors
Acupuncture to Prevent Chemotherapy Dose Reduction Due to Chemotherapy-induced Peripheral Neuropathy in Breast and Colorectal Cancer Patients (GCC1232
Phase I Study of SGI-110 With Irinotecan Followed by Randomized Phase II Study of SGI-110 With Irinotecan Versus Regorafenib or TAS-102 in Previously
An Interactive Preventive Health Record to Increase Colorectal Cancer Screening
Genistein in Treatment of Metastatic Colorectal Cancer
Cabozantinib and Panitumumab to Treat KRAS Wild-Type Metastatic Colorectal Cancer
Nonrandomized, Open-Label Phase IIb Efficacy Trial of Cancer Macrobeads Compared With Best Supportive Care in Patients With Treatment-Resistant Colore
An Investigational Immuno-therapy Study of Nivolumab, and Nivolumab in Combination With Other Anti-cancer Drugs, in Colon Cancer That Has Come Back or
Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer
Physical Activity Intervention for Older Patients During Chemotherapy for Colorectal Cancer
Cancer Associated Thrombosis and Isoquercetin (CAT IQ)
Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes
Patient-Centered Risk Adjusted Surveillance After Curative Resection of Colorectal Cancer
Evaluate the Efficacy of MEDI4736 in Immunological Subsets of Advanced Colorectal Cancer
CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery
Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced Gastrointestinal Malignancies Focusing on Hepatocellular Carcinoma
Increasing Colorectal Cancer (CRC) Screening Among Hispanic Primary Care Patients
Vorinostat Plus Hydroxychloroquine Versus Regorafenib in Colorectal Cancer
Inovio TRT-001: Telomerase DNA Immunotherapy in Breast, Lung, and Pancreatic Cancers
ColoCare Study - Colorectal Cancer Cohort
The Patient-Driven Self-Navigated Web-Based Family Outreach Program for Cancer Prevention in High-Risk Families
The Effect of Daratumumab on the Suppressive Function of Myeloid Derived Suppressor Cells (MDSCs) on T Cells
Improving Goals of Care Discussion in Advanced Cancer Patients
Increased Frequency of AlloStim® Immunotherapy Dosing in Combination With Cryoablation in Metastatic Colorectal Cancer
SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)
A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)
Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in NSCLC With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer
Patient Centered Outcomes Research Institute (PCORI) Provider Survey on Treatment Eligibility
Phase I/II Study of the Anti-Programmed Death Ligand-1 Antibody MEDI4736 in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and A
INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme
FOLFIRI and Panitumumab in Treating Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer
A Study of Enhancing Response to MK-3475 in Advanced Colorectal Cancer
A Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services
Efficacy and Tolerability of Suprep With and Without Simethicone for Routine Colonoscopy for Colorectal Cancer Screening
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangeme
A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer Subjects
Peptide Vaccine in Advanced Pancreatic Ductal Adenocarcinoma or Colorectal Adenocarcinoma
Effectiveness of High Dose Vitamin D Supplementation in Stage III Colorectal Cancer
A Trial of mFOLFIRI With MEK162 in Patients With Advanced KRAS Positive Metastatic Colorectal Cancers
Local Ablative Strategies After Endovascular Radioembolization
Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors
Study of the Safety, Tolerability and Efficacy of KPT-8602 in Patients With Relapsed/Refractory Cancer Indications
Phase 1/1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers
Programs To Support You During Chemotherapy
Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors
Survivorship Care Plan in Promoting Physical Activity in Breast or Colorectal Cancer Survivors in Wisconsin
Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid Tumors
Pain Coping Skills for Colorectal Cancer Survivors
Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by Surgery
Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer
S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Trial of Liver Resection Versus No Surgery in Patients With Liver and Unresectable Pulmonary Metastases From Colorectal Cancer (Liver Resection With U
A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer
Evaluation the Efficacy of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a S
Tremelimumab (Anti-CTLA-4) Plus Durvalumab (MEDI4736) (Anti-PD-L1) in the Treatment of Resectable Colorectal Cancer Liver Metastases
Regorafenib in Metastatic Colorectal Cancer
Microbiome, Exercise Tracking Study (METS)
Rural Interventions for Screening Effectiveness
Trial of Intraperitoneal (IP) Oxaliplatin in Combination With Intravenous FOLFIRI
PI Pembro in Combination With Stereotactic Body Radiotherapy for Liver Metastatic Colorectal Cancer
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
Safety and Efficacy of Intra-Arterial Ad-p53 in Liver Metastases of Solid Tumors
Use of ctDNA for Monitoring of Stage III Colorectal Cancer
The Beans to Enrich the Gut Microbiome vs. Obesity's Negative Effects (BE GONE) Trial
A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer
CB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal Cancer
Young-Onset Microsatellite-Stable Colorectal Cancer
Molecular Basis for Variations in Hereditary Colorectal Cancer Syndromes
Resection Versus Microwave Ablation for Resectable Colorectal Cancer Liver Metastases
Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung
Chemopreventive Effects of Epigallocatechin Gallate (EGCG) in Colorectal Cancer (CRC) Patients
Study of Irinotecan and AZD1775, a Selective Wee 1 Inhibitor, in RAS or BRAF Mutated, Second-line Metastatic Colorectal Cancer
Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (
Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.
Trial of Hu5F9-G4 in Combination With Cetuximab in Patients With Solid Tumors and Advanced Colorectal Cancer
Gut Microbiome in Fecal Samples From Patients With Metastatic Cancer Undergoing Chemotherapy or Immunotherapy
Survivor Choices for Eating and Drinking - Colorectal Cancer
Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma
GVAX for Colorectal Cancer
A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat
A Phase 1/2 Study to Investigate the Safety, Biologic and Anti-tumor Activity of ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Pe
Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention
Study of MK-8353 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Malignancies (MK-8353-013)
AZD9150 With MEDI4736 in Patients With Advanced Pancreatic, Non-Small Lung and Colorectal Cancer
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
An Analysis of the Impact of the Enhanced Recovery After Surgery System for Colorectal Surgery at the University of Arkansas for Medical Sciences
A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications
Assessing How Normal Variations in CT Scanning Affects Its Interpretation
Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004
Tucatinib (ONT-380) and Trastuzumab in Treating Patients With HER2+ Metastatic Colorectal Cancer
A Study of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)
Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver
A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
A Study of SC-006 in Subjects With Advanced Cancer
Panitumumab in Combination With Trametinib in Cetuximab-Refractory Stage IV Colorectal Cancer
Lay Health Worker Outreach in Increasing Colorectal Cancer Screening in Asian Americans
APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by Surgery
Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners
A Clinical Trial of Durvalumab and Tremelimumab, Administered With Radiation Therapy or Ablation in Patients With Colorectal Cancer
High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies
Participatory Research to Advance Colon Cancer Prevention
Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer
Small Media Interventions to Increase Colorectal Cancer Screening Among Chinese Americans
Integration of Cancer Health Activities Into African American Churches
Colorectal Cancer (CRC) Surveillance Tool: Cognitive and Pilot Testing
Exercise and Low-Dose Ibuprofen for Cognitive Impairment in Colorectal Cancer Patients Receiving Chemotherapy
Implementing Preemptive Pharmacogenomic Testing for Colorectal Cancer Patients in a Community Oncology Clinic
Study of Personalized Immunotherapy in Adults With Metastatic Colorectal Cancer
Oral STAT3 Inhibitor, C188-9, in Patients With Advanced Cancers
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
A Phase I/II Study of Pexa-Vec Oncolytic Virus in Combination With Immune Checkpoint Inhibition in Refractory Colorectal Cancer
Phase I/II Trial of Regorafenib, Hydroxychloroquine, and Entinostat in Metastatic Colorectal Cancer
Exercise Program During Chemotherapy in Metastatic Colorectal Cancer
Physical Activities by Technology Help (PATH)
Longitudinal Performance of Epi proColon
Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal C
Regorafenib Plus 5-Fluorouracil/Leucovorin Beyond Progression in mCRC
A Study of SC-007 in Subjects With Advanced Cancer
Molecular Determinants of Response to Preoperative Therapy in Patients With Locally Advanced Colorectal Cancer
A Study to Evaluate eFT508 Alone and in Combination With Avelumab in Subjects With MSS Colorectal Cancer
A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer or Metastatic Colorectal Cance
Study of Binimetinib + Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Microsatellite-stable (MSS) Metastatic Colorectal Cancer
Glutamine PET Imaging Colorectal Cancer
Study of Durvalumab and Tremelimumab After Radiation for Microsatellite Stable Metastatic Colorectal Cancer Progressing on Chemotherapy
Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Metastatic and Refractory RAS Wildtype Color
Durvalumab and Tremelimumab in Treating Patients With Microsatellite Stable Metastatic Colorectal Cancer to the Liver
Lidocaine for Oxaliplatin-induced Neuropathy
A Study of RO7198457 (Personalized Cancer Vaccine [PCV]) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced
Clinical Trial Evaluating the Safety and Response With PF-05082566, Cetuximab and Irinotecan in Patients With Advanced Colorectal Cancer
Study of TAS-102 Plus Radiation Therapy for the Treatment of the Liver in Patients With Hepatic Metastases From Colorectal Cancer
Child-Physician Recommendation on Parental Adherence to Colorectal Cancer Screening
Tailored Messaging for CRC Screening
A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors
FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors
Pembrolizumab in Combination With Ibrutinib for Advanced, Refractory Colorectal Cancers
A Study of CDX-1140 in Patients With Advanced Solid Tumors
A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine/Oxa
TAS102 in Combination With NAL-IRI in Advanced GI Cancers
VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer
Safety and Efficacy of Pembrolizumab (MK-3475) Plus Binimetinib Alone or Pembrolizumab Plus Chemotherapy With or Without Binimetinib in Metastatic Col
An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Patients With Previously Treated Can
Adaptive Intervention to Maximize Colorectal Screening in Safety Net Populations
U01 CRC Project for Vietnamese Americans
Genetic Risk: Whether, When, and How to Tell Adolescents
M7824 in Consensus Molecular Subtype 4, Treatment-Refractory Metastatic Colorectal Cancer
Evaluation for NCI Surgery Branch Clinical Studies
Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation Therapy
Health Education Materials With or Without a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III C
Open-Label Phase 2 Efficacy Trial of Cancer Macrobeads in Patients With Treatment-Resistant Pancreatic or Colorectal Cancer
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Hav
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
CYCORE: Cyberinfrastructure for Comparative Effectiveness Research - Feasibility Trial
Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (C
Phase 2 Study of MK-3475 in Patients With Microsatellite Unstable (MSI) Tumors
Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced Gastrointestinal Malignancies Focusing on Hepatocellular Carcinoma
Cancer Associated Thrombosis and Isoquercetin (CAT IQ)
CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery
Vorinostat Plus Hydroxychloroquine Versus Regorafenib in Colorectal Cancer
INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme
Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in NSCLC With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer
Phase I/II Study of the Anti-Programmed Death Ligand-1 Antibody MEDI4736 in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and A
Programs To Support You During Chemotherapy
A Study of Enhancing Response to MK-3475 in Advanced Colorectal Cancer
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangeme
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
Peptide Vaccine in Advanced Pancreatic Ductal Adenocarcinoma or Colorectal Adenocarcinoma
A Trial of mFOLFIRI With MEK162 in Patients With Advanced KRAS Positive Metastatic Colorectal Cancers
Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors
Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors
Study of the Safety, Tolerability and Efficacy of KPT-8602 in Patients With Relapsed/Refractory Cancer Indications
Phase 1/1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers
Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid Tumors
Pain Coping Skills for Colorectal Cancer Survivors
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer
PI Pembro in Combination With Stereotactic Body Radiotherapy for Liver Metastatic Colorectal Cancer
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer
CB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal Cancer
Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung
A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat
A Study of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)
Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors
Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (
Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.
Trial of Hu5F9-G4 in Combination With Cetuximab in Patients With Solid Tumors and Advanced Colorectal Cancer
A Phase 1/2 Study to Investigate the Safety, Biologic and Anti-tumor Activity of ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Pe
Survivor Choices for Eating and Drinking - Colorectal Cancer
Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma
Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention
Study of MK-8353 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Malignancies (MK-8353-013)
Evaluation for NCI Surgery Branch Clinical Studies